166 related articles for article (PubMed ID: 1505460)
21. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
22. Partial characterization of a parathyroid hormone-stimulated resorption factor(s) from osteoblast-like cells.
Perry HM; Skogen W; Chappel J; Kahn AJ; Wilner G; Teitelbaum SL
Endocrinology; 1989 Oct; 125(4):2075-82. PubMed ID: 2791978
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K
J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
[TBL] [Abstract][Full Text] [Related]
24. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
25. The effects of parathyroid hormone or 1,25-dihydroxyvitamin D3 on monocyte-osteoclast fusion.
Teti A; Volleth G; Carano A; Zambonin Zallone A
Calcif Tissue Int; 1988 May; 42(5):302-8. PubMed ID: 3135098
[TBL] [Abstract][Full Text] [Related]
26. [Osteoblastic regulation of osteoclast survival: effect of calcitriol].
Mentaverri R; Lorget F; Wattel A; Maamer M; Kamel S; Brazier M
C R Acad Sci III; 2000 Nov; 323(11):951-7. PubMed ID: 11144027
[TBL] [Abstract][Full Text] [Related]
27. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
28. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells.
Fuller K; Owens JM; Chambers TJ
J Endocrinol; 1998 Sep; 158(3):341-50. PubMed ID: 9846163
[TBL] [Abstract][Full Text] [Related]
29. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
30. Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix.
Fuller K; Gallagher AC; Chambers TJ
Biochem Biophys Res Commun; 1991 Nov; 181(1):67-73. PubMed ID: 1958220
[TBL] [Abstract][Full Text] [Related]
31. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
32. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.
Takahashi N; Akatsu T; Sasaki T; Nicholson GC; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Sep; 123(3):1504-10. PubMed ID: 2841098
[TBL] [Abstract][Full Text] [Related]
33. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
[TBL] [Abstract][Full Text] [Related]
35. Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?
Jilka RL
Bone Miner; 1986 Sep; 1(4):261-6. PubMed ID: 2849485
[TBL] [Abstract][Full Text] [Related]
36. Macrophage colony-stimulating factor release and receptor expression in bone cells.
Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
[TBL] [Abstract][Full Text] [Related]
37. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
38. Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells.
Udagawa N; Sasaki T; Akatsu T; Takahashi N; Tanaka S; Tamura T; Tanaka H; Suda T
Biochem Biophys Res Commun; 1992 Apr; 184(1):67-72. PubMed ID: 1567458
[TBL] [Abstract][Full Text] [Related]
39. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
40. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
Nishiyama K; Sugimoto T; Kaji H; Kanatani M; Kobayashi T; Chihara K
Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
